WallStreetZenWallStreetZen

NASDAQ: VVOS
Vivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?

Insider buying vs selling

Have Vivos Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ronald Kirk HuntsmanChief Executive Officer2023-06-2014,000$0.53
$7.42kBuy
Ronald Kirk HuntsmanChief Executive Officer2023-06-165,000$0.53
$2.65kBuy
Ronald Kirk HuntsmanChief Executive Officer2023-06-1610,000$0.54
$5.40kBuy
Ronald Kirk HuntsmanChief Executive Officer2023-06-1521$0.50
$10.50Buy
Ronald Kirk HuntsmanChief Executive Officer2023-06-1410,000$0.49
$4.90kBuy

1 of 1

VVOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VVOS insiders and whales buy or sell their stock.

VVOS Shareholders

What type of owners hold Vivos Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ronald Kirk Huntsman130.91%3,575,521$9.44MInsider
Gurdev Dave Singh117.88%3,219,705$8.50MInsider
Strategic Wealth Investment Group LLC4.72%128,789$340.00kInstitution
Armistice Capital LLC2.09%57,000$150.48kInstitution
Schonfeld Strategic Advisors LLC1.83%50,100$132.26kInstitution
Vanguard Group Inc0.39%10,579$27.93kInstitution
Blue Trust Inc0.15%4,000$10.56kInstitution
Credit Agricole S A0.09%2,365$6.24kInstitution
Bradford K. Amman0.07%2,000$5.28kInsider
Tower Research Capital LLC Trc0.06%1,718$4.54kInstitution

1 of 3

VVOS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VVOS3.64%96.36%Net Buying
HSCS1.84%1.37%
OPGN1.28%98.72%
AIMD0.13%99.87%Net BuyingNet Buying
INBS20.85%77.09%Net Buying

Vivos Therapeutics Stock Ownership FAQ

Who owns Vivos Therapeutics?

Vivos Therapeutics (NASDAQ: VVOS) is owned by 9.41% institutional shareholders, 248.87% Vivos Therapeutics insiders, and 0.00% retail investors. Ronald Kirk Huntsman is the largest individual Vivos Therapeutics shareholder, owning 3.58M shares representing 130.91% of the company. Ronald Kirk Huntsman's Vivos Therapeutics shares are currently valued at $9.48M.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.